Pharmaceutical, Biotech and medical device companies work along with researchers, doctors and patients to develop drugs and devices to improve the health of patients. Drug development is long and cumbersome process that may take unto 10 years for development. Hence, industry require incentive to invest years of development in specific diseases. A joint effort, government incentives, and collaborative environment will incentivize industry to focus on “orphan” drug development.